Literature DB >> 3485879

Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.

G M Lauro, N Di Lorenzo, M Grossi, A Maleci, B Guidetti.   

Abstract

Cultured human glioma cells were found to produce soluble factors that can modulate the in vitro proliferative response of purified T lymphocytes stimulated by phytohemagglutinin (PHA). Neoplastic tissue was removed during surgery for brain glial tumors and cultured in vitro. The glial nature of the neoplastic cells was verified by means of anti-glial fibrillary acidic protein immunohistochemical staining. Serum-free supernatants from these cultures proved capable of suppressing in vitro proliferation of PHA-stimulated T lymphocytes. Suppression was reduced when indomethacin or aspirin was added to the culture medium. Thin-layer chromatography revealed the presence of prostaglandins and other arachidonic acid derivatives in the supernatants. The radioimmunoassay used to quantify the prostaglandin E2 (PGE2) in the supernatants showed detectable amounts of PGE2, which disappeared after the cultures had been treated with anti-inflammatory drugs. These data support the hypothesis that tumoral glial cells can play a role in the host immune response in the central nervous system, namely by producing soluble factors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485879     DOI: 10.1007/BF00688305

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (Ia) on their surface.

Authors:  R P Lisak; M Hirayama; D Kuchmy; A Rosenzweig; S U Kim; D E Pleasure; D H Silberberg
Journal:  Brain Res       Date:  1983-12-19       Impact factor: 3.252

2.  Extraction and thin-layer chromatography of arachidonic acid metabolites.

Authors:  J A Salmon; R J Flower
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

3.  Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.

Authors:  S Carrel; N De Tribolet; N Gross
Journal:  Eur J Immunol       Date:  1982-04       Impact factor: 5.532

4.  Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.

Authors:  C Solheid; G Lauro; G Palladini
Journal:  J Neurol Sci       Date:  1976-11       Impact factor: 3.181

5.  Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations.

Authors:  M A Gerosa; A Olivi; M L Rosenblum; G P Semenzato; A Pezzutto
Journal:  Neurosurgery       Date:  1982-05       Impact factor: 4.654

6.  Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.

Authors:  C Walker; F Kristensen; F Bettens; A L deWeck
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Biological and biochemical characterization of an interleukin 1-like factor from rat C6 glioma cells.

Authors:  A Fontana; K P McAdam; F Kristensen; E Weber
Journal:  Eur J Immunol       Date:  1983-08       Impact factor: 5.532

8.  Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells.

Authors:  G M Lauro; C Solheid; L Medolago-Albani; N Di Lorenzo; B Guidetti
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Lymphokine-like products of cultured tumour cells.

Authors:  Y Inoue; C L Geczy; D S Nelson; M Nelson
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

10.  Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.

Authors:  L H Elliott; W H Brooks; T L Roszman
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

View more
  14 in total

1.  Effect of human T lymphotropic retrovirus-I exposure on cultured human glioma cell lines.

Authors:  B Macchi; B Caronti; M Pezzella; E Bonmassar; G Lauro
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Heterogeneity maintenance in glioblastoma: a social network.

Authors:  Rudy Bonavia; Maria-del-Mar Inda; Webster K Cavenee; Frank B Furnari
Journal:  Cancer Res       Date:  2011-05-31       Impact factor: 12.701

Review 3.  Vaccine-based immunotherapeutic approaches to gliomas and beyond.

Authors:  Michael Weller; Patrick Roth; Matthias Preusser; Wolfgang Wick; David A Reardon; Michael Platten; John H Sampson
Journal:  Nat Rev Neurol       Date:  2017-05-12       Impact factor: 42.937

4.  In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.

Authors:  Y Sawamura; A C Diserens; N de Tribolet
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

5.  The alteration of prostaglandin E2 levels in patients with brain tumors before and after tumor removal.

Authors:  Joon-Khim Loh; Shiuh-Lin Hwang; Ann-Shung Lieu; Tzuu-Yuan Huang; Shen-Long Howng
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  Role of mitochondrial complex I and protective effect of CoQ10 supplementation in propofol induced cytotoxicity.

Authors:  Christian Bergamini; Noah Moruzzi; Francesco Volta; Laura Faccioli; Jantje Gerdes; Maria Cristina Mondardini; Romana Fato
Journal:  J Bioenerg Biomembr       Date:  2016-08-15       Impact factor: 2.945

7.  Human astroglial but not microglial cells synthesize alpha 2-macroglobulin in vitro.

Authors:  G M Lauro; C Fabrizi; R Businaro; L Fumagalli; S Torelli; F Gremo
Journal:  Ital J Neurol Sci       Date:  1992-11

8.  Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines.

Authors:  R Businaro; C Fabrizi; L Fumagalli; G M Lauro
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

9.  Cell-mediated cytotoxicity in glioma-bearing patients: differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen.

Authors:  C Ausiello; A Maleci; G C Spagnoli; G Antonelli; A Cassone
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

10.  Immunological studies in patients with central nervous system tumors.

Authors:  L Palma; V Moschese; E Galli; C Barbieri; V R Lombardi; P Rossi
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.